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mammalian lipid metabolism. The enzymes that regulate fatty acid and cholestrol biosynthesis are acetyl-CoA carboxylase and 3-hydroxymethylglutaryl-CoA reductase, respectively. Hormonal regulation of each is achieved through their phosphorylation and inactivation by AMP-PK. Like many other serine kinases, AMP-PK is allostaically activated by a small molecular weight ligand (in this case pM 5' AMP) and is itself phosphorylated and activated by a distinct kinase kinase [I, 21. In addition to these regulatory mechanisms, many protein kinases have specific endogenous protein or peptide inhibitors that are pseudosubstrates (ie. contain the protein kinase consensus recognition sequence but lack the target senne). For example, Walsh inhibitor is a heat-stable, 12KDa endogenous protein that is a pseudosubstrate for cyclic AMPdependent protein kinase [3] . Similar but less well characterised protein and peptide inhibitors exist for other protein kinases such as protein lrinase C [4, 5] . The dilution of crude tissue extracts for the assay of AMP-PK activity often leads anomalously to increased activity which suggests that an inhibitor may have been diluted away [6, MRM unpublished] .
This study has identified an inhibitor of AMP-PK in rat liver and skeletal muscle. We have parhally purified these inhibitory activities using a 2040% ammonium sulphate precipitation and application of the resuspended protein pellet to a DE52 anion exchange column on FPUJ followed by elution with 35OmM NaCI. The achvity of the inhibitor was assessed by its ability to inhibit the incorporation of 32P from [y-32P]-ATP into the specific peptide substrate HMRSAMSLHLVKRR (based on the phosphorylation site on acetylCoA cahxylase) by purified rat liver AMP-PK. A full description of the AMP-PK assay is given in 171. Some p r o v e s of the inhibitory activities of the post-DE52 fractions from both liver and skeletal muscle have been investigated. Both inhibited AMP-PK in a concentration-dependent manner. Full inhibition was not time-dependent but observed within the 5 minutes assay time for AMP-PK activity. Typical levels of inhibition seen were 90% from liver, and 2040% from muscle preparations.
However, both preparations are considerably impure (confirmed by SDS-PAGE) so that one could not compare the specific activities of muscle and liver inhibitors B'i'iPure 1.
The ability of post-DE52 fractions from rat skeletal muscle and liver to inhibit AMP-PK activity was tested using the assay described in 171 but over a pH range using Mes pH 5.5-6.5, Hepes pH 7.0-8.0 and Tricine pH 8.0-9.0 as buffers. Results are expressed as the levels of inhibition of AMP-PK measured at each pH in order to correct for the pH sensitivity of AMP-PK itself. Figure 2 Ileat labilitv of AMP-PK inactivator Post-DE52 inhibitory fractions from skeletal muscle and liver were incubated for 1 hour at temperatures ranging from 3oOC-8OOC. Aftex this preincubation an aliquot of each was assayed for its ability to inhibit AMP-PK activity as described for Figure The DE52 fraction from liver maximally inhibited AMP-PK activity over a very broad pH range giving 90% inhibition at pH values ranging from 6.5-9.0 ( Figure I ). In contrast, skeletal muscle showed little or no inhibitory activity at the higher and lower pHs tested, and showed a distinct pH optimum profile with maximum inhibition of AMP-PK (45%) at pH 8.0 (Figure 1) . Both inhibitory activities were heat-labile with muscle more so than liver (Figure 2) . The muscle inhibitor lost approximately 50% of its activity with every 1BC increase in temperature, while liver inhibitor retained its activity until 6OOC and then rapidly lost all of its activity between 6ooc and 8W (Figure 2) .
Given the intricate nature of the mechanisms that regulate protein kinases, the physiological role of endogenous inhibitors is unclear. The liver is the major site of lipid biosynthesis and AMP-PK activity is highest in this tissue and yet an endogenous inhibitor appears to be present. Skeletal muscle has low rates of lipid biosynthesis and AMP-PK activity is very low 161 even though both mRNA and AMP-PK protein are abundant (D Carling, personal communication) . Thus the presence of an endogenous inhibitor may be one mechanism by which AMP-PK activity is supressed and the presence of an endogenous inhibitor in skeletal muscle may have physiological significance. All assays were performed in the presence of the protein phosphatase inhibitors, NaF and NaPR which inhibit protein phosphates 2A and 1, but not 2C. Since protein phosphatase 2C has been r e p o d to dephosphorylate and inactivate AMP-PK [8] there is a possibility that it is contributing the inhibitory activity. However, the non-time-dependence of the inhibition observed and the heat stability of the liver inhibitor make such a possibility doubtful. The differences in pH dependence and heat lability of the inhibitory activity from liver and muscle ( Figures   1 and 2 ) may suggest that they are different. However, further purification and characterisation is required to establish whether they are indeed W n s and whether they are the same enhty.
